🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, multi-center, double-blind, double-dummy, placebo-con...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00383552
This is a 2-week double-blind, placebo-controlled, parallel group study com...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00635882
Persistent allergic rhinitis in children is commonly treated with intranasa...
Status
Completed
Location
Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital
Start Date
2025-01-02
Trial ID
NCT07593898
Mometasone furoate (MF) is a synthetic glucocorticosteroid that, when admin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01026870
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability \& effectiv...
Status
Completed
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01566149
This study compares the 12-week efficacy and 24-week safety of mometasone f...
Status
Completed
Location
Multiple Locations
Start Date
2016-05-11
Trial ID
NCT02741271
This was an open-label, multiple-dose, study of mometasone furoate/formoter...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-01
Trial ID
NCT00604500
Treatments Being Tested
The purpose of this study is to assess the effect of one of five possible s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01615874
The purpose of this study is to test the safety of DULERA. DULERA is a pres...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-09
Trial ID
NCT01471340
The primary objective of this study is to demonstrate the dose-related effi...
Status
Completed
Location
Multiple Locations
Start Date
2012-01-25
Trial ID
NCT01502371
Treatments Being Tested